Stocklytics Platform
Asset logo for symbol CNC
Centene
CNC73
$73.10arrow_drop_up8.45%$5.70
S&P500
Asset logo for symbol CNC
CNC73

$73.10

arrow_drop_up8.45%
Key Stats
Open$69.45
Prev. Close$67.40
EPS5.07
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
LOWHIGH
Day Range69.29
74.28
52 Week Range60.83
81.42
Ratios
Revenue-
EPS5.07
Fundamentals
Payout Ratio-
Industry average yield2.85%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell
Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

CNCarrow_drop_up0.84%
US Healthcare Sectorarrow_drop_up0.50%
US Marketarrow_drop_down1.27%
check_circle
CNC / Market
CNC exceeded the US Market which returned -1.27% over the last twenty four hours.
check_circle
CNC / Healthcare Sector
CNC exceeded the US Healthcare sector which returned 0.50% over the last twenty four hours.

Centene (CNC) Statistics

Centene Corp (CNC) is a leading healthcare enterprise that provides government-sponsored healthcare programs. The company offers a range of services, including Medicaid, Medicare, and Health Insurance Marketplace plans. With its strong focus on improving healthcare outcomes, Centene has become a trusted partner for millions of individuals across the United States.
When looking at CNC's stock statistics, several key metrics stand out. Firstly, the valuation metrics indicate that CNC is an attractive investment. The stock has a relatively low price-to-earnings (P/E) ratio, suggesting that it is undervalued compared to its earnings. Additionally, Centene Corp has a favorable enterprise-to-EBITDA ratio, which highlights its strong financial performance and potential for growth.
In terms of fundamentals, Centene Corp demonstrates solid financial health. The company has a healthy profit margin, indicating its ability to generate profits from its operations. Furthermore, Centene Corp has managed its debt effectively, with a moderate total debt level. These sound fundamentals provide a stable foundation for the company's future growth and sustainability.
When considering stock performance, Centene Corp has outperformed its sector in recent years. The stock has consistently delivered strong returns to investors, driven by the company's robust revenue per share growth. This growth highlights Centene's ability to increase its top line and generate value for shareholders. Overall, Centene Corp's stock performance is a testament to its successful business strategy and execution.
Finally, the CEO of Centene Corp plays a crucial role in the company's success. Under the leadership of Michael F. Neidorff, Centene has achieved significant milestones and solidified its position as a leading healthcare enterprise. Neidorff's strategic vision and industry expertise have guided Centene's growth and expansion, making him an integral part of the company's success.
To summarize, Centene Corp (CNC) exhibits strong stock statistics and valuation metrics, making it an attractive investment opportunity. The company's solid fundamentals, including a healthy profit margin and manageable debt level, underline its financial stability. Centene has also outperformed its sector, driven by steady revenue per share growth. These positive trends reflect the successful execution of Centene's business strategy. Moreover, the leadership of CEO Michael F. Neidorff has been instrumental in the company's achievements. Overall, Centene Corp is well-positioned for continued growth and success in the healthcare industry.
add Centene to watchlist

Keep an eye on Centene

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
How has Centene (CNC) stock's performance compared to its sector and the market over the past year?
Over the past year, Centene (CNC) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 24.98%, Centene has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 51.99%, it has fallen short of the market average. This comparison highlights Centene's performance relative to both its sector and the overall market over the last year.
help
What is the PE ratio of Centene (CNC) stock?
The PE (Price to Earnings) ratio of Centene (CNC) is currently 14.42. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help
What is the EPS of Centene (CNC) stock?
The Earnings Per Share (EPS) for Centene (CNC), calculated on a diluted basis, is $5.07. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help
What is the operating margin of Centene (CNC) stock?
The operating margin for Centene (CNC) is 4.39%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help
What is the EBITDA of Centene (CNC) stock?
The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Centene (CNC) is $4.62B. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help
How much debt does Centene (CNC) have?
Centene (CNC) has a total debt of $18B. The net debt, which accounts for cash and cash equivalents against the total debt, is $415M.
email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level